Athena Athena

X

147086-79-1 manufacturers and suppliers on PharmaCompass

PharmaCompass
4H-Thieno[2,3-b]thiopyran-4-one, 5,6-dihydro-6-methyl-, (6S)-
Also known as: 147086-79-1, (6s)-5,6-dihydro-6-methyl-4h-thieno[2,3-b]thiopyran-4-one, (6s)-6-methyl-5,6-dihydrothieno[2,3-b]thiopyran-4-one, 4h-thieno[2,3-b]thiopyran-4-one,5,6-dihydro-6-methyl-, (6s), 4h-thieno[2,3-b]thiopyran-4-one, 5,6-dihydro-6-methyl-, (s)-, 4h-thieno[2,3-b]thiopyran-4-one, 5,6-dihydro-6-methyl-, (6s)-
Molecular Formula
C8H8OS2
Molecular Weight
184.3  g/mol
InChI Key
FLJFMDYYNMNASJ-YFKPBYRVSA-N

1 2D Structure

4H-Thieno[2,3-b]thiopyran-4-one, 5,6-dihydro-6-methyl-, (6S)-

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(6S)-6-methyl-5,6-dihydrothieno[2,3-b]thiopyran-4-one
2.1.2 InChI
InChI=1S/C8H8OS2/c1-5-4-7(9)6-2-3-10-8(6)11-5/h2-3,5H,4H2,1H3/t5-/m0/s1
2.1.3 InChI Key
FLJFMDYYNMNASJ-YFKPBYRVSA-N
2.1.4 Canonical SMILES
CC1CC(=O)C2=C(S1)SC=C2
2.1.5 Isomeric SMILES
C[C@H]1CC(=O)C2=C(S1)SC=C2
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 147086-79-1

2. (6s)-5,6-dihydro-6-methyl-4h-thieno[2,3-b]thiopyran-4-one

3. (6s)-6-methyl-5,6-dihydrothieno[2,3-b]thiopyran-4-one

4. 4h-thieno[2,3-b]thiopyran-4-one,5,6-dihydro-6-methyl-, (6s)

5. 4h-thieno[2,3-b]thiopyran-4-one, 5,6-dihydro-6-methyl-, (s)-

6. 4h-thieno[2,3-b]thiopyran-4-one, 5,6-dihydro-6-methyl-, (6s)-

7. Schembl1122649

8. (6s)-6-methyl-4h,5h,6h-thieno[2,3-b]thiopyran-4-one

9. Zinc38672075

10. Akos015895956

11. Ac-22716

12. As-75583

13. Cs-0264523

14. En300-93026

15. D97171

2.3 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 184.3 g/mol
Molecular Formula C8H8OS2
XLogP32.4
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count3
Rotatable Bond Count0
Exact Mass184.00165722 g/mol
Monoisotopic Mass184.00165722 g/mol
Topological Polar Surface Area70.6 Ų
Heavy Atom Count11
Formal Charge0
Complexity181
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
147086-79-1
Bhavna Laboratories Pvt. Ltd., founded in 1986, is an Indian company that specializes in manufacturing AP...
Bhavna Laboratories Pvt. Ltd., founded in 1986, is an Indian company that specializes in manufacturing APIs and intermediates. Besides being approved by the FDA of India, Bhavna has obtained cGMP certificates for all the drugs it manufactures. It also conforms to WHO GMP standards. With a focus on muscle relaxants and ophthalmic products, Bhavna provides custom manufacturing services for APIs and intermediates. Bhavna’s facility near Mumbai, India, adheres to cGMP regulations and has a yearly production capacity of over 500 tonnes. Bhavna Laboratories exports its products to various countries in Southeast Asia, the Middle East, and Europe.
Bhavna Labs

2024 Spring Meeting

Not Confirmed

envelop Contact Supplier
Flag India
Digital Content Digital Content
URL Supplier Web Content
147086-79-1
The Bakul Group of companies headquartered in Mumbai, India are engaged in the development and manufactur...
The Bakul Group of companies headquartered in Mumbai, India are engaged in the development and manufacture of high-quality Active Pharmaceutical Ingredients (APIs), Intermediates, and Speciality Chemicals. Since our inception in 1975, we have grown to become world leaders in the area of xanthine chemistry. They specialize in manufacturing APIs such as Linagliptin, Pentoxifylline, Theobromine, Doxofylline, Caffeine, Pamabrom, and others.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY